Remove tag value-based-healthcare
article thumbnail

Upcoming sickle cell gene therapies cost effective at $2 million, says ICER

Pharmaceutical Technology

Two gene therapies up for approval this year for sickle cell disease could be cost effective in some cases at a $2 million price point, based on a draft evidence report published by the Institute for Clinical and Economic Review (ICER). If approved, exa-cel would be the first FDA-approved gene therapy based on CRISPR editing.

article thumbnail

Grand Rounds July 7, 2023: Implementing Virtual Strategies Across an Integrated Healthcare System: The IMPLEMENT-HF Study (Ankeet S. Bhatt, MD, MBA, ScM)

Rethinking Clinical Trials

The daily workflow consisted of a daily electronic health record (EHR) query that identified patients who had heart failure with reduced ejection fraction, who were admitted for any cause within sites in the healthcare system. Salem Hospital is affiliated with the health care system but is a community-based hospital.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Grand Rounds May 5, 2023: All of Us Research Program: Improving Health Through Diverse Technology, Huge Cohorts, and Precision Medicine (Joshua C. Denny, MD, MS)

Rethinking Clinical Trials

Returning value is a key part of the program. The Researcher Workbench is a cloud-based central resource with a passport access model. nonprofits and nonprofit/for-profit academic and healthcare organizations. We want trials to adhere to our core values and have the data come back to our ecosystem.

Medicine 130
article thumbnail

Amylyx ALS drug draws criticism over $158,000 price tag

pharmaphorum

Currently, the ALS drug is priced about five times higher than the top of a value-based range. Following news of Relyvrio’s $158,000 annual price tag, both ALS advocates and outside observers have voiced outrage at the cost. The post Amylyx ALS drug draws criticism over $158,000 price tag appeared first on.

Drugs 52
article thumbnail

AI-Powered Precision Engagement in Commercial and Medical Functions

Intouch Solutions

In the pharma industry, precision engagement can be used to present patients, healthcare professionals (HCPs), and other stakeholders with relevant information and support at the right time. This process is relatively straightforward when high-value medical-scientific content is readily available.

article thumbnail

Preview of Pharma Commercials at Super Bowl 2024: From Touching Down with TUMS to Tackling Menopause

XTalks

Along with the hefty price tag for screen time that may not be perceived to be a worthwhile investment, and despite favoring advertising at other major events like the Grammys, pharma tends to stay somewhat clear of all the Super Bowl hoopla. Bayer is preparing to file for FDA approval based on strong Phase III data it shared last month.

article thumbnail

Clover Biopharmaceuticals Announces Publication of Phase 1 Clinical Trial Data for its Adjuvanted COVID-19 Vaccine Candidates in The Lancet

The Pharma Data

The S-Trimer vaccine candidates and adjuvants are expected to be stable long term at refrigerator temperatures (2-8 o C) and have demonstrated stability at room temperature for at least two months, making these constructs suitable for broad global distribution based on current results. About Trimer-Tag© Technology.